Geographic Analysis of Cancer Patients' Residences at Delafontaine Hospital

Status

Not yet recruiting

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT07206914

Enrollment

300

Registered

2025-10-03

Start date

2025-10-15

Completion date

2026-04-15

Last updated

2025-10-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Inequalities, Health Services Accessibility, Neoplasms, Oncology Service, Residence Characteristics, Transportation of Patients

Brief summary

This study looks at where cancer patients treated at Delafontaine Hospital live and how far they have to travel for care. By mapping patients' home addresses (anonymized), the research will show how distance, transportation, and social factors affect access to cancer treatments and support services. The goal is to better understand inequalities in access to care and to improve patient support in the future.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Inclusion criteria

\- Adult patients treated for cancer in the oncology department of Delafontaine Hospital since January 1, 2020.

Exclusion criteria

\- Patients whose cancer treatment in the oncology department was completed before 2020.

Design outcomes

Primary

Measure	Time frame
Median travel time (minutes) from the patient's place of residence (IRIS centroid) to Delafontaine Hospital by the patient's usual mode of transport for oncology appointments.	Assessed up to 5 years after first inclusion

Countries

France

Outcome results